Israeli and British medical research teams are to collaborate to find cures for cancer and genetic diseases.
A joint research memorandum has been signed between the Technion Israel Institute of Technology, the University of Manchester and Central Manchester University Hospitals to jointly fund stem-cell and cancer studies.
Students and researchers will also be able to travel between the Manchester and Haifa-based leading research centres under the agreement.
Technion’s Prof Eliezer Shalev described it as an “exciting opportunity”.